The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Complement C3 Variant and the Risk of Age-Related Macular Degeneration
Open accessAbstract
BACKGROUND: Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation is implicated in the pathogenesis. METHODS: We tested for an association between age-related macular degeneration and 13 single-nucleotide polymorphisms (SNPs) spanning the complement genes C3 and C5 in case subjects and control subjects from the southeastern region of England. All subjects were examined by an ophthalmologist and had independent grading of fundus photographs to confirm their disease status. To test for replication of the most significant findings, we genotyped a set of Scottish cases and controls. RESULTS: The common functional polymorphism rs2230199 (Arg80Gly) in the C3 gene, corresponding to the electrophoretic variants C3S (slow) and C3F (fast), was strongly associated with age-related macular degeneration in both the English group (603 cases and 350 controls, P=5.9x10(-5)) and the Scottish group (244 cases and 351 controls, P=5.0x10(-5)). The odds ratio for age-related macular degeneration in C3 S/F heterozygotes as compared with S/S homozygotes was 1.7 (95% confidence interval [CI], 1.3 to 2.1); for F/F homozygotes, the odds ratio was 2.6 (95% CI, 1.6 to 4.1). The estimated population attributable risk for C3F was 22%. CONCLUSIONS: Complement C3 is important in the pathogenesis of age-related macular degeneration. This finding further underscores the influence of the complement pathway in the pathogenesis of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the fast migrating allotype (C3F), has been reported to be strongly associated with AMD in a study from English and Scottish populations (Yates et al., 2007).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Yates et al., 2007
In the citing paper
“We further confirmed the association with family history of AMD, consistent with the growing recognition of major genes involved in AMD (e.g., complement factor H and C3, LOCS 3877, HTRA 1) [21,83-86].”
From Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis (2010) · cites this paper as [86]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [7]
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [170]
In the citing paper
“The complement system may indeed have an important role in the pathogenesis of age-related macular degeneration, since other factors such as factor B and complement components C2 and C3 are also associated with age-related macular degeneration.66,67”
From Age-related macular degeneration (2008) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,969
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Self-citationThe AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration
DeWan, A., Liu, M., Hartman, S., Zhang, S. S.-M., Liu, D. T. L., Zhao, C., Tam, P. O. S., Chan, W. M., Lam, D. S. C., Snyder, M., et al. (2006) · Science · doi:10.1126/science.1133807 · Cited by 876
Research works printed but not linked: 2
- Rambausek M, 1987, Nephrol Dial Transplant, 2, 208
- Finn JE, 1994, Nephrol Dial Transplant, 9, 1564
Cited by
Sorted by citations
Items 501–600 of 834
Lü, F., Shi, Y., Qu, C., Zhao, P., Liu, X., Gong, B., Ma, S., Zhou, Y., Zhang, Q., Fei, P., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11381 · Cited by 18
Association of C-Reactive Protein Genetic Polymorphisms With Late Age-Related Macular Degeneration
Cipriani, V., Hogg, R. E., Sofat, R., Moore, A. T., Webster, A. R., Yates, J. R. W., FLETCHER, A. E., & for the European Eye (EUREYE) Study Group (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2191 · Cited by 16
Self-citationLi, S., Li, D., Shao, M., Cao, W., & Sun, X. (2018) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001014 · Cited by 16
Schnabolk, G., Obert, E., Banda, N. K., & Rohrer, B. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.14.11 · Cited by 16
Jia, H., Li, T., Sun, J., Gong, Y., Liu, H., Wang, H., Chen, J., Liu, W., Lu, S., Feng, L., et al. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.11.016 · Cited by 17
Yu, Q., Yao, Y., Zhu, J., Xin, B., Xie, T., Sun, C., & Cao, J. (2015) · Gene · doi:10.1016/j.gene.2015.02.039 · Cited by 16
ARMS2 interference leads to decrease of proinflammatory mediators
Zeng, F., Zhang, M., Xu, Y., & Xu, H. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2442-0 · Cited by 16
Genetic Association Analysis of Drusen Progression
Hoffman, J., van Grinsven, M. J. J. P., Li, C., Brantley, M. A., McGrath, J. A., Agarwal, A., Scott, W. K., Schwartz, S. G., Kovach, J. L., Pericak‐Vance, M. A., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18571 · Cited by 18
Hughes, A. E., Bridgett, S., Meng, W., Li, M., Curcio, C. A., Stambolian, D., & Bradley, D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18744 · Cited by 16
Age-Related Macular Degeneration
Rosenfeld, P. J., Martidis, A., & TENNANT, M. T. S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-04332-8.00100-1 · Cited by 16
Bailey, J. N. C., Pericak‐Vance, M. A., & Haines, J. L. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017186 · Cited by 16
Bringing the genetics of macular degeneration into focus
Haines, J. L., Spencer, K. M., & Pericak-Vance, M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708151104 · Cited by 15
Pharmacogenetics and Age-Related Macular Degeneration
Schwartz, S. G., & Brantley, M. A. (2011) · Journal of Ophthalmology · doi:10.1155/2011/252549 · Cited by 15
Goldberg, M. R., Frémeaux‐Bacchi, V., Koch, P., Fishelson, Z., & Katz, Y. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.020 · Cited by 15
Pinna, A., Zinellu, A., TENDAS, D., Blasetti, F., Carru, C., & Castiglia, P. (2015) · Current Eye Research · doi:10.3109/02713683.2014.1002044 · Cited by 15
Yamashiro, K., Hosoda, Y., Miyake, M., Takahashi, A., Ooto, S., & Tsujikawa, A. (2020) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-020-00773-w · Cited by 15
Humphries, M. M., Kenna, P. F., Campbell, M., Tam, L. C. S., Nguyen, A. T. H., Farrar, G. J., Botto, M., Kiang, A. S., & Humphries, P. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.151 · Cited by 15
Frederick, P. A., & Kleinman, M. E. (2014) · Current Ophthalmology Reports · doi:10.1007/s40135-013-0037-x · Cited by 18
Peter, I., & Seddon, J. M. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.06.012 · Cited by 15
Handa, J. T., Tagami, M., Ebrahimi, K. B., Leibundgut, G., Janiak, A., Witztum, J. L., & Tsimikas, S. (2015) · Europe PMC (PubMed Central) · Cited by 15
Annamalai, B., Parsons, N., Belhaj, M., Brandon, C. S., Potts, J. D., & Rohrer, B. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.2.3 · Cited by 15
Maroñas, O., García‐Quintanilla, L., Luaces-Rodríguez, A., Fernández‐Ferreiro, A., Latorre, A., Abraldes, M. J., Lamas, M. J., & Carracedo, Á. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190711105325 · Cited by 15
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype
Loane, E., Nolan, J. M., McKay, G. J., & Beatty, S. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.07.005 · Cited by 14
Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization
Grob, S., Luo, J., Hughes, G., Lee, C., Zhou, X., Lee, J., Du, H., Ferreyra, H. A., Freeman, W. R., Kozak, I., et al. (2012) · Eye · doi:10.1038/eye.2012.107 · Cited by 14
Wang, J.-H., Wong, R. C. B., & Liu, G. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.4.32 · Cited by 15
Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy
Sato, Y., Ueda‐Arakawa, N., Takahashi, A., Miyake, M., Mori, Y., Miyara, Y., Hara, C., Kitajima, Y., Maruko, R., Kawai, M., et al. (2024) · Ophthalmology Science · doi:10.1016/j.xops.2024.100528 · Cited by 14
Parekh, Z., Xiao, J. F., Mani, A., Evans, Q., Phung, C., Barba, H., Xie, B., Sidebottom, A. M., Sundararajan, A., Lin, H., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.4.21 · Cited by 14
Whole exome sequencing of extreme age-related macular degeneration phenotypes.
Sardell, R. J., Bailey, J. N. C., Courtenay, M. D., Whitehead, P. L., Laux, R. A., Adams, L. D., Fortun, J. A., Brantley, M. A., Kovach, J. L., Schwartz, S. G., et al. (2016) · Europe PMC (PubMed Central) · Cited by 14
AICAR suppresses TNF-α-induced complement factor B in RPE cells
Chung, E. J., Efstathiou, N. E., Konstantinou, E. K., Maidana, D. E., Miller, J. W., YOUNG, L. H. Y., & Vavvas, D. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-17744-w · Cited by 14
Association of chronic hepatitis B virus infection with age‐related macular degeneration
Wu, C., Su, F., Wang, W., Lin, C., Kamiza, A. B., Chang, S., & Yeh, C. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14032 · Cited by 14
AMD Genetics: Methods and Analyses for Association, Progression, and Prediction
Yan, Q., Ding, Y., Weeks, D. E., & Chen, W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_7 · Cited by 14
Zhu, Y. O., Natoli, R., Valter, K., & Stone, J. (2010) · PubMed Central · Cited by 14
El‐Halawany, N., Shawky, A.-E.-M., Al-Tohamy, A., Hegazy, L., Abdel-Shafy, H., Abdel-Latif, M. A., Ghazi, Y. A., Neuhoff, C., Salilew‐Wondim, D., & Schellander, K. (2017) · Journal of Genetics · doi:10.1007/s12041-017-0740-8 · Cited by 14
Gorin, M. B., & daSilva, M. J. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107894 · Cited by 14
Wang, X., Zhang, Y., & Zhang, M.-N. (2013) · PubMed Central · doi:10.3980/j.issn.2222-3959.2013.06.21 · Cited by 14
The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy
Moir, J. T., Hyman, M. J., Gonnah, R., Flores, A., Hariprasad, S. M., & Skondra, D. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.3.23 · Cited by 13
Immunogenetic and Environmental Factors in Age-Related Macular Disease
Brodzka, S., Baszyński, J., Rektor, K., Hołderna-Bona, K., Stanek, E., Kurhaluk, N., Tkaczenko, H., Malukiewicz, G., Woźniak, A., & Kamiński, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126567 · Cited by 13
No association between the T280M polymorphism of the CX3CR1 gene and exudative AMD
Zerbib, J., Puche, N., Richard, F., Leveziel, N., Cohen, S. Y., Korobelnik, J., Sahel, J., Münnich, A., Kaplan, J., Rozet, J., et al. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.05.005 · Cited by 13
McCarthy, L. C., Newcombe, P. J., Whittaker, J. C., Wurzelmann, J. I., Fries, M. A., Burnham, N. R., Cai, G., Stinnett, S. W., Trivedi, T., & Xu, C. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.021 · Cited by 13
Yeh, C., Wu, M., Wu, C., Sung, F.-C., Muo, C., Te, A., & Su, F. (2021) · Viruses · doi:10.3390/v13050790 · Cited by 13
Hallam, T. M., Cox, T. E., Smith‐Jackson, K., Brocklebank, V., Baral, A. J., Tzoumas, N., STEEL, D. H., Wong, E. K. S., Shuttleworth, V. G., Lotery, A. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028760 · Cited by 15
Polygenic Risk Score Impact on Susceptibility to Age-Related Macular Degeneration in Polish Patients
Wąsowska, A., Teper, S. J., Matczyńska, E., Łyszkiewicz, P., Sendecki, A., Machalińska, A., Wylęgała, E., & Boguszewska‐Chachulska, A. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010295 · Cited by 13
Emerging opportunities for C3 inhibition in the eye
Kim, B. J., Liu, T., Mastellos, D. C., & Lambris, J. D. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101633 · Cited by 14
Beykin, G., Grunin, M. A., Averbukh, E., Banin, E., Hemo, Y., & Chowers, I. (2015) · BMC Ophthalmology · doi:10.1186/s12886-015-0019-x · Cited by 13
Bonyadi, M. J., Gol, T. M., Bonyadi, M. H. J., Fotouhi, N., Soheilian, M., Javadzadeh, A., Moein, H.-R., & Yaseri, M. (2016) · Ophthalmic Genetics · doi:10.3109/13816810.2015.1126612 · Cited by 12
Efstathiou, N. E., Moustafa, G. A., Maidana, D. E., Konstantinou, E. K., Notomi, S., Barbisan, P. R. T., Georgakopoulos, C. D., Miller, J. W., & Vavvas, D. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244307 · Cited by 12
Gibson, B. G., Cox, T. E., & Marchbank, K. J. (2022) · Immunological Reviews · doi:10.1111/imr.13141 · Cited by 12
Tsiftsoglou, S. A., Gavriilaki, E., Touloumenidou, T., Koravou, E., Koutra, M., Papayanni, P. G., Karali, V., Papalexandri, A., Varelas, C., Chatzopoulou, F. M., et al. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152351 · Cited by 12
Nucleocytoplasmic transport at the crossroads of proteostasis, neurodegeneration and neuroprotection
Ferreira, P. A. (2023) · FEBS Letters · doi:10.1002/1873-3468.14722 · Cited by 12
Complement component C3 allotypes and outcomes in liver transplantation
Dhillon, N. K., Walsh, L., Krüger, B., Mehrotra, A., Ward, S. C., Godbold, J., Radwan, M., Schiano, T. D., Murphy, B. T., & Schröppel, B. (2010) · Liver Transplantation · doi:10.1002/lt.21972 · Cited by 12
Age-Related Macular Degeneration
Kumaramanickavel, G. (2016) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000223 · Cited by 12
Linetsky, M. D., Bondelid, K. S., Losovskiy, S., Gabyak, V., Rullo, M. J., Stiadle, T. I., Munjapara, V., Saxena, P., Ma, D., Cheng, Y.-S., et al. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00028 · Cited by 12
Trouw, L. A., Böhringer, S., Daha, N. A., Stahl, E. A., Raychaudhuri, S., Kurreeman, F. A. S., Stoeken‐Rijsbergen, G., Houwing‐Duistermaat, J. J., Huizinga, T. W. J., & Toes, R. E. M. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04482.x · Cited by 12
Saksens, N. T. M., Lechanteur, Y. T. E., Verbakel, S. K., Groenewoud, J. M. M., Daha, M. R., Schick, T., Fauser, S., Boon, C. J. F., Hoyng, C. B., & den Hollander, A. I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144367 · Cited by 12
Mattes, D., Haas, A., Renner, W., Steinbrugger, I., El‐Shabrawi, Y., Wedrich, A., Werner, C., Schmut, O., & Weger, M. (2009) · PubMed Central · Cited by 12
Kato, Y., Oguchi, Y., Omori, T., Kasai, A., Ogasawara, M., Sugano, Y., Itagaki, K., Ojima, A., Ishida, Y., Machida, T., et al. (2022) · Ophthalmology Science · doi:10.1016/j.xops.2022.100167 · Cited by 11
Biber, J., Jabri, Y., Glänzer, S., Dort, A., Hoffelner, P., Schmidt, C. Q., Bludau, O., Pauly, D., & Grosche, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03045-3 · Cited by 11
Anti-inflammatory Effects of GTE in Eye Diseases
Li, J., Du, L., He, J. N., Chu, K. O., Guo, C. L., Wong, M. O. M., Pang, C. P., & Chu, W. K. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.753955 · Cited by 11
Hung, S., Xirasagar, S., Kuang, T.-M. T., Chang, W., Cheng, Y., Kuo, N., & Lin, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040602 · Cited by 11
Fu, Y., Chen, X., Luo, S., Jiang, S., Mao, Y., & Xiao, W. (2023) · Nutrients · doi:10.3390/nu15051216 · Cited by 11
Leban, N., Jraba, K., Chalghoum, A., Hassine, S., Hayek, D., Denden, S., Lakhdhar, R., Maatoug, F., Gamra, H., Braham, H., et al. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-93 · Cited by 11
Xu, D., Hou, S., Zhang, J., Jiang, Y., Kijlstra, A., & Yang, P. (2015) · Scientific Reports · doi:10.1038/srep12989 · Cited by 11
The inhibition of NOTCH2 reduces UVB-induced damage in retinal pigment epithelium cells
Liu, L., Zhou, X., Kuang, X., Long, C., Liu, W., Tang, Y., Liu, H., He, J., Huang, Z., Fan, Y., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6625 · Cited by 11
Genetic Control of Complement Activation in Humans and Age Related Macular Degeneration
Hecker, L. A., & Edwards, A. O. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_4 · Cited by 11
Spencer, K. L., Olson, L. M., Schnetz‐Boutaud, N. C., Gallins, P. J., Wang, G., Scott, W. K., Agarwal, A., Jakobsdóttir, J., Conley, Y. P., Weeks, D. E., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-5112 · Cited by 11
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration
Kaiser, P. K. (2007) · Core evidence · doi:10.2147/ce.s7437 · Cited by 11
Looking beyond Lucentis on the management of macular degeneration
Fletcher, E. C., & Chong, V. N. (2008) · Eye · doi:10.1038/sj.eye.6703008 · Cited by 11
Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response
Chaudhary, V., Brent, M., Lam, W.-C., Devenyi, R., Teichman, J., Mak, M., Barbosa, J., Kaur, H., Carter, R., & Farrokhyar, F. (2016) · Ophthalmologica · doi:10.1159/000446819 · Cited by 10
Mishra, M., Kim, H.-H., Youm, Y.-H., Gonzalez-Hurtado, E., Zaitsev, K., Dlugos, T., Shchukina, I., Gliniak, C., Ravussin, E., Mohanty, S., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01107-0 · Cited by 10
The Relationship between Complements and Age-Related Macular Degeneration and Its Pathogenesis
Chu, L., Bi, C., Wang, C., & Zhou, H. (2024) · Journal of Ophthalmology · doi:10.1155/2024/6416773 · Cited by 11
Rajesh, A., Gong, J., Chan, K. S., Viniak, R., Droho, S., Kachar, D., Strauss, J. Y., Wang, A. L., & Lavine, J. A. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03398-3 · Cited by 10
Baird, P. N., & Chakrabarti, S. (2013) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12235 · Cited by 10
Neto, J. M., Viturino, M. G. M., Ananina, G., Bajano, F. F., Costa, S. M. D. S., Roque, A. B., Borges, G. F. D. S., Franchi, R., Rim, P. H. H., Medina, F. M. C., et al. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211024543 · Cited by 10
Pacheco, V. B., Nery, G. C. L., Fernandes, L. L., Santana, T. V., Jiménez, M., Borges, L., Hatanaka, E., Braga, P. L. G., Monteiro, F. R., do Amaral, J. B., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3725056 · Cited by 10
Age-Related Macular Degeneration
Harris, G., Pratt, S. G., & RICHER, S. P. (2012) · CRC Press eBooks · doi:10.1201/b13694-3 · Cited by 10
Chlamydia infection status, genotype, and age-related macular degeneration.
Khandhadia, S., Foster, S., Cree, A. J., Griffiths, H., Osmond, C., Goverdhan, S. V., & Lotery, A. J. (2012) · Europe PMC (PubMed Central) · Cited by 10
Qian, D.-G., Kan, M., Weng, X., Huang, Y., Zhou, C., Gen-long, Y., Wang, T., Zhou, D., Zhang, Z., Zhang, D., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.37 · Cited by 10
Kim, J.-B., & Lad, E. M. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00822-6 · Cited by 11
MALONDIALDEHYDE LEVELS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
Pinna, A., Boscia, F., Paliogiannis, P., Carru, C., & Zinellu, A. (2019) · Retina · doi:10.1097/iae.0000000000002574 · Cited by 10
The Landscape of Vascular Endothelial Growth Factor Inhibition in Retinal Diseases
Lin, J. B., & Apte, R. S. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.1.47 · Cited by 9
Liu, Y., Liu, L., Yu, N., Dai, L., Stella, C., Chang, V., Kaur, S., Xu, K., & Wakshull, E. (2020) · Bioanalysis · doi:10.4155/bio-2020-0097 · Cited by 9
Complement Gene Single Nucleotide Polymorphisms and Biomarker Endophenotypes of Alzheimer's Disease
Daborg, J., Holmgren, S., Abramsson, A., Andréasson, U., Zetterberg, M., Nilsson, S., Minthon, L., Skoog, I. G., Blennow, K., Pekna, M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121930 · Cited by 9
de Pedro‐Cuesta, J., Martínez‐Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. J. G., Almazán‐Isla, J., Ruiz-Tovar, M., Medrano, M.-J., Avellanal, F., Calero, O., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150884 · Cited by 9
Rare Genetic Variants in Jewish Patients Suffering from Age-Related Macular Degeneration
Shoshany, N., Weiner, C., Safir, M., Lifshitz, A. E., Pokroy, R., Kol, A., Modai, S., Shomron, N., & Pras, E. (2019) · Genes · doi:10.3390/genes10100825 · Cited by 10
Acar, İ. E., Willems, E., Kersten, E., Keizer-Garritsen, J. J., Kragt, E., Bakker, B., Galesloot, T. E., Hoyng, C. B., Fauser, S., van Gool, A. J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121256 · Cited by 9
Bazyar, N., Azarpira, N., Khatami, S. R., & Galehdari, H. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1759-9 · Cited by 9
Li, F., Li, Y., Li, M., Sun, Y., Bai, Y., Yang, F., Guo, J., Chen, Y., Huang, L., & Li, X. (2014) · Ophthalmic Research · doi:10.1159/000357978 · Cited by 9
Hyperbaric oxygen therapy and age-related macular degeneration.
Weiss, J. N. (2010) · PubMed · Cited by 9
Complement Factor H: Using Atomic Resolution Structure to Illuminate Disease Mechanisms
Barlow, P. N., Hageman, G. S., & Lea, S. M. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_10 · Cited by 9
Ho, L., van Leeuwen, R., de Jong, P. T. V. M., Vingerling, J. R., & Klaver, C. C. W. (2012) · Springer eBooks · doi:10.1007/978-3-642-22107-1_1 · Cited by 9
Kenney, M. C., Estrago-Franco, M., Moustafa, M. T., Riazi-Esfahani, M., Sapkal, A. U., Piche-Lopez, R., Patil, A. J., Sharma, A., Falatoonzadeh, P., Chwa, M., et al. (2016) · Journal of Ophthalmic and Vision Research · doi:10.4103/2008-322x.194091 · Cited by 9
Novel score test to increase power in association test by integrating external controls
Li, Y., & Lee, S. (2020) · Genetic Epidemiology · doi:10.1002/gepi.22370 · Cited by 10
Association Between Serum Complement C3 Levels and Age-Related Cataract
Shao, M., Li, D., Teng, J., Zhang, Y., Li, S., & Cao, W. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22522 · Cited by 8
Liu, K., Ma, L., Lai, T. Y. Y., Brelen, M. E., Tam, P. O. S., Tham, C. C. Y., Pang, C. P., & Chen, L. J. (2019) · Eye and Vision · doi:10.1186/s40662-019-0161-2 · Cited by 8
Differential expression of plasma exosomal microRNA in severe acute pancreatitis
Xu, Y., Sun, Y., Yin, R., Dong, T., Song, K., Yang, F., Liu, G., Shen, B., & Li, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.980930 · Cited by 8
Hallam, T. M., Andreadi, A., Sharp, S. J., Brocklebank, V., Gardenal, E., Dreismann, A. K., Arora, R., Dennis, M., Flaxel, C. J., Hall, E., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107452 · Cited by 8
Tilleul, J., Richard, F., Puche, N., Zerbib, J., Leveziel, N., Sahel, J., Cohen, S. Y., Korobelnik, J., Feingold, J., Münnich, A., et al. (2013) · Europe PMC (PubMed Central) · Cited by 8
Pigmentepithelabhebung bei exsudativer Makuladegeneration
Lommatzsch, A. P. (2010) · Der Ophthalmologe · doi:10.1007/s00347-010-2143-6 · Cited by 8
Complement Activation and Inhibition in Retinal Diseases
Kleinman, M. E., & Ambati, J. (2015) · Developments in ophthalmology · doi:10.1159/000431141 · Cited by 8
Tsiftsoglou, S. A. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.03.021 · Cited by 8
Metadata
- Authors
- Yates, J. R. W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., Armbrecht, A. M., Dhillon, B., Deary, I. J., Redmond, E., Bird, A. C., & Moore, A. T.
- Affiliations
- University of Cambridge (GB)
- MRC Human Genetics Unit (GB)
- Princess Alexandra Eye Pavilion (GB)
- University of Edinburgh (GB)
- University College London (GB)
- Moorfields Eye Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-08-09
- Volume
- 357
- Issue
- 6
- Pages
- 553-561
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2105479207
- Cited by
- 829
- References
- 41
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 30 · 2023: 22 · 2022: 27 · 2021: 30 · 2020: 28 · 2019: 25 · 2018: 25 · 2017: 33 · 2016: 36 · 2015: 52 · 2014: 57 · 2013: 66 · 2012: 81
- FWCI
- 63.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Wellcome Trust
- Moorfields Eye Hospital NHS Foundation Trust
- Directorate for Biological Sciences
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, complement C3, single nucleotide polymorphisms, complement activation, genetic susceptibility, population attributable risk, pathogenesis
- MeSH terms
- Aged, Complement C3, Complement C5, Female, Genotype, Humans, Macular Degeneration, Male, Logistic Models, Odds Ratio, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Structure, Quaternary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
